[FDG-PET/CT in oncology. German Guideline]

Nuklearmedizin. 2007;46(6):291-301. doi: 10.3413/nukmed-282.
[Article in German]


FDG-PET/CT examinations combine metabolic and morphologic imaging within an integrated procedure. Over the past decade PET/CT imaging has gained wide clinical acceptance in the field of oncology. This FDG-PET/CT guideline focuses on indications, data acquisition and processing as well as documentation of FDG-PET/CT examinations in oncologic patients within a clinical and social context specific to Germany. Background information and definitions are followed by examples of clinical and research applications of FDG-PET/CT. Furthermore, protocols for CT scanning (low dose and contrast-enhanced CT) and PET emission imaging are discussed. Documentation and reporting of examinations are specified. Image interpretation criteria and sources of errors are discussed. Quality control for FDG and PET/CT-systems, qualification requirements of personnel as well as legal aspects are presented.

Publication types

  • Practice Guideline

MeSH terms

  • Documentation
  • Fluorodeoxyglucose F18*
  • Humans
  • Neoplasms / diagnostic imaging*
  • Positron-Emission Tomography / standards*
  • Radiopharmaceuticals*
  • Tomography, X-Ray Computed / standards*


  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18